Bal Pharma consolidated net profit declines 31.73% in the September 2025 quarter
Sales rise 0.45% to Rs 74.02 crore
Net profit of Bal Pharma declined 31.73% to Rs 0.71 crore in the quarter ended September 2025 as against Rs 1.04 crore during the previous quarter ended September 2024. Sales rose 0.45% to Rs 74.02 crore in the quarter ended September 2025 as against Rs 73.69 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales74.0273.69 0 OPM %7.7410.44 -PBDT2.993.84 -22 PBT0.721.36 -47 NP0.711.04 -32Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 13 2025 | 7:50 AM IST